Rising Star Awards

Prostate Cancer Canada (PCC) is proud to debut the Rising Star in Prostate Cancer Research program, which provide salary and research support for outstanding research scientists initiating careers as independent investigators in prostate cancer research.

These awards provide the opportunity for research scientists within the first 5 years of their first academic or research appointment to develop and demonstrate independence in initiating and conducting prostate cancer research.

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • prostate cancer biology
  • treatment
  • diagnosis
  • survivorship
  • prevention
The amount available for this program is subject to funds raised. The number of awards to be distributed is contingent upon availability of resources and the quality of applications received. The current plan is to distribute four awards with a maximum amount per award of $150,000 per year ($75,000 for salary support and $75,000 for research expenses) for up to 3 years.

For more details on this award, please click here.


2012 Rising Star in Prostate Cancer Research
Review Panel

If you are seeking clarifications, please refer to the FAQs prior to contacting PCC. The FAQs document will continue to be updated as questions are put forward.
Kim Chi, Co-chair
 

Anne-Marie Mes-Masson, Co-chair


Glenn Baumann


Inka Brockhausen


Ralph Buttyan


Gerardo Ferbeyre


Jacques Lapointe


Winston Isaac
Vancouver Prostate Centre
Vancouver, BC

Centre de recherché du Centre Hospitalier de l'Université de Montréal
Montreal, QC

University of Western Ontario
London, ON

Queen’s University
Kingston, ON

Vancouver Prostate Centre
Vancouver, BC

University of Montreal
Montreal, QC

McGill University Health Centre Research Institute
Montreal, QC

Lay member   
Brampton, ON

 

 

Support PSA Tests


Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Prostate cancer researchers develop personalized genetic test to accurately predict recurrence risk

TORONTO, ON - November 13, 2014 – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. More

Prostate Cancer Canada reminds men that early detection using ‘Smart Screening’ for prostate cancer

Toronto, ON – October 27, 2014 – Prostate Cancer Canada responds today to guidelines released from The Canadian Task Force on Preventive Health Care (CTFPHC) recommending that the Prostate Specific Antigen (PSA) test should be eliminated as a screening tool for prostate cancer. More


Click here for news archive